Video Experimental Relacionado
Updated: May 8, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.8K
Evaluación de la administración de carboximaltosa férrica en pacientes de edad avanzada: resultados clínicos,
María Noemí García-Calderón Díaz1, Antonio Medina Nieto1, Mateo Ballesteros Arana1
1Servicio de Geriatría, Hospital Central de la Cruz Roja San José y Santa Adela, Madrid, Spain.
Revista espanola de geriatria y gerontologia
|August 29, 2025
Resumen
La carboximaltosa férrica es un tratamiento de hierro intravenoso seguro y eficaz para pacientes ancianos. La administración de esta terapia en el hogar o en hogares de ancianos es rentable, mejorando el acceso y reduciendo los gastos de atención médica.
Área de la Ciencia:
- Medicina para la edad avanzada
- Farmacología
- Economía de la salud
Sus antecedentes:
- La anemia por deficiencia de hierro es común en los ancianos.
- La carboximaltosa férrica intravenosa se utiliza cada vez más para el tratamiento.
- La evaluación de su uso en diversos entornos de atención es crucial.
Objetivo del estudio:
- Evaluar la seguridad y eficacia de la carboximaltosa férrica en pacientes de edad avanzada.
- Evaluar la rentabilidad de su administración en diferentes entornos de atención.
- Analizar los resultados clínicos y las reacciones adversas durante cinco años.
Principales métodos:
- Estudio de cohorte observacional retrospectivo de 198 pacientes de edad avanzada.
- Datos recogidos sobre la demografía de los pacientes, los factores clínicos y las reacciones adversas.
- Análisis de costos que compara la administración de hospitales geriátricos con la de hogares de ancianos.
Principales resultados:
- El tratamiento fue generalmente seguro con reacciones adversas leves (5,73%) que afectaron principalmente a la presión arterial.
- Los pacientes en hogares de ancianos tenían mayor fragilidad y comorbilidad.
- La administración por una unidad de hospitalización en hogares geriátricos mostró un ahorro potencial de 39.353,80 €.
Conclusiones:
- La carboximaltosa férrica es segura y eficaz para pacientes ancianos frágiles.
- La administración en el hogar o en el asilo es rentable.
- Este enfoque puede mejorar la accesibilidad y reducir los costos de atención médica.
Videos de Conceptos Relacionados
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...